Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is a paper indexed in PICO Portal from OpenAlex.
How many citations does Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study have?
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study has 184 citations in the OpenAlex counts PICO Portal stores.
When was Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study published?
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study has 2016 year in the PICO Portal index.
What is the open-access status of Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study has hybrid oa status in the PICO Portal index.
What is the DOI of Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?
The DOI for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is on the source record.
What is the PMID of Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?
The PMID for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is on the source record.
What is the OpenAlex record for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study?
The OpenAlex for Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study is on the source record.